BDR Pharma inks license agreement with DRDO to produce COVID-19 drug 2-DG

Last month, the Drugs Controller General of India (DCGI) had approved the oral medication for emergency usage as adjuvant therapy in mild to severe COVID-19 patients.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news